NEW YORK – The Association for Molecular Pathology released preliminary survey results on Tuesday showing that molecular testing for cancer declined significantly during the COVID-19 pandemic.
NEW YORK – The Association for Molecular Pathology released preliminary survey results on Tuesday showing that molecular testing for cancer declined significantly during the COVID-19 pandemic.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.
Privacy Policy. Terms & Conditions. . Copyright © 2021 GenomeWeb, a business unit of Crain Communications. All Rights Reserved.